MU
Marshall Urist sold $239K of RPRX stock
Marshall Urist, EVP, Research & Investments of Royalty Pharma plc (RPRX), sold 4,126 shares of RPRX stock worth $239K, per an SEC Form 4 filed Sep 30, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 28, 2026, 2 days before it was made public.
RPRX has moved +18.2% since the trade date, from $58.37 to $68.97 (Nov 12, 2026 close).
- Traded
- Sep 28, 2026
- Disclosed
- Sep 30, 2026
- Filing delay
- 2 days
- Price since
- +18.2%
- Role
- EVP, Research & Investments
- Source
- SEC Form 4